Immunitas Therapeutics, Inc.

Biotechnology company · Waltham, Massachusetts, United States

Immunitas Therapeutics, Inc. is a biotechnology company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $29 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Immunitas Therapeutics at a glance

Typebiotechnology company

HeadquartersWaltham, Massachusetts, United States

Earliest incorporation on record2019

SEC CIK1879910

What does Immunitas Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $29.1 million sold (2021).

Frequently asked questions about Immunitas Therapeutics

Where is Immunitas Therapeutics headquartered?

Immunitas Therapeutics, Inc. is headquartered in Waltham, Massachusetts, United States.

What does Immunitas Therapeutics do?

Immunitas Therapeutics, Inc. is a biotechnology company.

When was Immunitas Therapeutics founded?

The earliest incorporation on record for Immunitas Therapeutics, Inc. is in 2019, according to public company registers.

Similar companies

Repligen CorpWaltham, Massachusetts, United States
TScan Therapeutics, Inc.Waltham, Massachusetts, United States
La Jolla Pharmaceutical CoWaltham, Massachusetts, United States
MINERVA BIOTECHNOLOGIES CorpWaltham, Massachusetts, United States
Dianthus Therapeutics, Inc.Waltham, Massachusetts, United States
Viridian Therapeutics, Inc.Waltham, Massachusetts, United States
Pyramid Biosciences, Inc.Waltham, Massachusetts, United States
Mythic Therapeutics, Inc.Waltham, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences